Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.786 EUR | -0.63% |
|
-5.72% | -2.90% |
05-01 | Transcript : Chimerix, Inc., Q1 2024 Earnings Call, May 01, 2024 | |
05-01 | Chimerix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 34 | 100.0 % | 0 | 100.0 % | -99.04% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 34 | 100.0 % | 0 | 100.0 % | -99.04% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Andriole
CEO | Chief Executive Officer | 51 | 07/04/19 |
Director of Finance/CFO | 50 | 31/12/10 | |
Michael Sherman
CHM | Chairman | 58 | 07/04/19 |
Caryn Barnett
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/19 |
Allen Melemed
CTO | Chief Tech/Sci/R&D Officer | 60 | 21/06/20 |
Joshua Allen
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/20 |
Thomas Riga
COO | Chief Operating Officer | 48 | 11-15 |
General Counsel | - | 07/08/22 | |
David Jakeman
AUD | Comptroller/Controller/Auditor | 47 | 31/12/08 |
Roy W. Ware
PRN | Corporate Officer/Principal | - | 31/12/06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Middleton
BRD | Director/Board Member | 74 | 27/03/18 |
Martha Demski
BRD | Director/Board Member | 71 | 31/12/04 |
Michael Sherman
CHM | Chairman | 58 | 07/04/19 |
Pratik Multani
BRD | Director/Board Member | 57 | 23/02/20 |
Robert Meyer
BRD | Director/Board Member | 65 | 27/03/18 |
Lisa Decker
BRD | Director/Board Member | 55 | 12-27 |
Director/Board Member | 60 | 25/04/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 89,629,902 | 83,667,912 ( 93.35 %) | 0 | 93.35 % |
Company contact information
![address Chimerix, Inc.(CXF)](https://cdn.zonebourse.com/static/address/50918364.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.58% | 122B | |
+16.60% | 113B | |
+17.55% | 26.22B | |
-24.33% | 19.01B | |
-19.14% | 15.71B | |
-17.95% | 15.22B | |
-46.81% | 14.72B | |
+58.78% | 14.58B | |
+4.91% | 13.84B |
- Stock Market
- Equities
- CMRX Stock
- CXF Stock
- Company Chimerix, Inc.